Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.86 USD | -0.53% | 0.00% | -17.33% |
29/03 | TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
06/02 | Knight Therapeutics Announces Launch of Bijuva in Canada | MT |
Chart calendar TherapeuticsMD, Inc.
Upcoming events on TherapeuticsMD, Inc.
Past events on TherapeuticsMD, Inc.
30/03/2024 01:30 am | Q4 2023 Earnings Release |
15/11/2023 02:35 am | Q3 2023 Earnings Release |
14/08/2023 04:20 pm | Q2 2023 Earnings Release |
26/06/2023 05:30 pm | Annual General Meeting |
16/05/2023 01:35 am | Q1 2023 Earnings Release |
08/04/2023 01:31 am | Q4 2022 Earnings Release |
15/11/2022 02:35 am | Q3 2022 Earnings Release |
15/08/2022 06:00 pm | Interim 2022 Earnings Call |
15/08/2022 04:20 pm | Interim 2022 Earnings Release |
17/05/2022 02:00 am | Q1 2022 Earnings Call |
17/05/2022 01:35 am | Q1 2022 Earnings Release |
10/03/2022 07:00 pm | FY 2021 Earnings Call |
10/03/2022 05:20 pm | FY 2021 Earnings Release |
11/11/2021 07:00 pm | Q3 2021 Earnings Call |
11/11/2021 05:20 pm | Q3 2021 Earnings Release |
04/08/2021 06:00 pm | Interim 2021 Earnings Call |
04/08/2021 04:20 pm | Interim 2021 Earnings Release |
27/05/2021 05:30 pm | Annual General Meeting |
06/05/2021 06:00 pm | Q1 2021 Earnings Call |
06/05/2021 04:30 pm | Q1 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 49,6 41,4 19.86% | 64,9 63,3 2.43% | 87,0 97,3 -10.62% | 70,0 92,6 -24.45% |
EBITDA Million USD | Released Forecast Spread | -151 -152 0.68% | -154 -141 -9.4% | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -151 -152 0.5% | -156 -144 -8.33% | -140 -131 -6.29% | 1,19 -73,5 101.62% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -176 -176 -0.22% | -184 -171 -7.57% | -172 -163 -5.71% | 1,07 23,8 -95.49% |
Net income Million USD | Released Forecast Spread | -176 -176 -0.23% | -184 -171 -7.57% | -172 -163 -5.71% | 112 23,5 376.58% |
EPS USD | Released Forecast Spread | -36,0 -34,9 -3.16% | -33,5 -30,5 -9.84% | -21,5 -20,2 -6.61% | 12,0 2,47 384.21% |
Announcement Date | 20/02/20 | 02/03/21 | 10/03/22 | 08/04/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 18,7 29,4 -36.45% | 19,3 18,0 7.67% | 28,6 23,2 23.11% | 20,9 30,2 -30.74% | 1,15 23,8 -95.16% | 0,42 1,70 -75.53% | 0,44 0,50 -12.6% |
EBIT Million USD | Released Forecast Spread | -35,4 -26,7 -32.35% | -26,2 -27,5 4.51% | -18,8 -23,5 19.99% | 67,0 -7,70 970.23% | -2,67 0,70 -481% | -2,47 -0,70 -253.14% | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -43,0 -33,3 -29.06% | -49,0 -34,0 -44.05% | 113 -26,4 527.67% | -33,5 -10,8 -210.29% | -2,31 0,70 -430% | -2,41 -0,70 -244.86% | |
Net income Million USD | Released Forecast Spread | -43,0 -33,3 -29.06% | -49,0 -34,0 -44.05% | 112 -26,4 525.58% | 77,7 -10,8 819.46% | -3,60 0,60 -700.5% | -2,41 -0,70 -244.86% | |
EPS USD | Released Forecast Spread | -5,00 -3,83 -30.43% | -5,69 -4,00 -42.25% | 12,4 -3,04 507.57% | -3,13 -2,04 -53.43% | 8,23 -1,11 841.44% | -0,37 0,06 -716.67% | -0,24 -0,07 -242.86% |
Announcement Date | 10/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 08/04/23 | 15/05/23 | 14/08/23 |
Past sector events for TherapeuticsMD, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TXMD Stock
- Calendar TherapeuticsMD, Inc.